Prevention


Exercise Prescription: A Core Component of CVD Prevention and Treatment

An American College of Cardiology scientific statement emphasizes that exercise should be prescribed as a core component of cardiovascular disease (CVD) prevention and management, with the greatest absolute benefits occurring when physically inactive individuals begin exercising. The statement provides practical guidance for tailoring aerobic, resistance, balance, and flexibility training to […]


Lipid-Rich Plaques That May Benefit From Preventive PCI

Preventive PCI was associated with a substantially lower risk of major cardiac events in patients with near-infrared spectroscopy–defined lipid-rich plaques (LRPs), but not in those without LRPs, suggesting that plaque composition may be more informative than plaque size alone in selecting lesions for preventive treatment. In this post hoc analysis […]


Heart-Healthy Eating: Focus on the Overall Dietary Pattern

A healthy, balanced dietary pattern—not an emphasis on individual nutrients or foods—is central to preventing and managing cardiovascular and cardiometabolic disease, according to a new American College of Cardiology Scientific Statement. The statement reviews evidence on macronutrients, micronutrients, dietary patterns, ultra-processed foods, and emerging nutrition-based interventions, emphasizing that heart-healthy eating […]


Cancer-Associated Coagulopathy–Related Stroke

A systematic review of 82 studies found that stroke related to cancer-associated coagulopathy (CAC) is a distinct, often underrecognized condition characterized by early occurrence, frequent recurrence, characteristic imaging findings, and high mortality. CAC-related stroke occurs predominantly within six months of cancer diagnosis and is strongly associated with advanced or metastatic […]


WHO Dementia Prevention Guidelines Updated

To reduce the risk of cognitive decline and/or dementia specifically, the WHO just released updated guidance and dementia-specific recommendations: cognitive training may be offered to older adults with normal cognition or mild cognitive impairment and engagement in cognitive stimulation may be encouraged. Engagement in social activity interventions may be recommended. […]


Intensive Lifestyle Intervention Reduces Long-Term Multimorbidity in Prediabetes

US Adults with prediabetes who participated in an intensive lifestyle intervention had a significantly lower risk of developing multiple chronic diseases over 25 years, while metformin did not provide a similar benefit. This long-term follow-up of the Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) included 1,173 […]


2026 Key Recommendations for Preventing and Managing Cardiovascular-Kidney-Metabolic Syndrome

Preventing progression and promoting regression of cardiovascular-kidney-metabolic (CKM) syndrome requires early staging, comprehensive risk assessment, management of risk factors, and use of evidence-based therapies across the life course. CKM syndrome staging is recommended for youths and adults to guide treatment and reduce cardiovascular and kidney complications. Individuals with CKM stages […]


Prediabetes Remission Confers Long-Term Protection against CVD

Achieving remission of prediabetes was associated with an approximately 50% lower long-term risk of death from cardiovascular disease (CVD) or hospitalization for heart failure, with benefits persisting for decades in two landmark diabetes prevention cohorts. In post hoc analyses of the US Diabetes Prevention Program Outcomes Study and the Chinese […]


The Surprising Gap in Heart Attack Prediction

Traditional atherosclerotic cardiovascular disease (ASCVD) risk- and symptom-based screening misses nearly half of patients under age 66 who go on to experience their first myocardial infarction (MI), revealing major shortcomings in current preventive strategies. In this US retrospective study of 465 adults presenting with a first type 1 MI, simulation […]


Secondary CVD Prevention with Colchicine

Low-dose colchicine reduces myocardial infarction and stroke in people with cardiovascular disease (CVD) without increasing serious adverse events, although it raises the risk of mild gastrointestinal symptoms and shows no clear effect on mortality or revascularization. In an updated Cochrane review of 12 randomized controlled trials including 22,983 participants followed […]